跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Amgen Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 30, 2024
Approval ID
ae9730a7bc1b9356
Company
Amgen Europe B.V.
Type
Standard
Approval Details
Approval Id
ae9730a7bc1b9356
Drug Cima Aemps Name
REPATHA 140 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
1151016003IP
Holder Company Name
Amgen Europe B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/amgen-europe-b-v
Authorization Date
2024-05-30
Dosage Form
SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose
140 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Amgen Europe B.V.
Company Detail Path
/organization/amgen-europe-b-v
Company Information
Pharmaceutical Company Name
AMGEN EUROPE B.V.
Country Name
Israel
City Name
tel aviv-jaffa,central district,country_il
Address
Simtat Maoz
Active Ingredients
EVOLOCUMAB
140 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 30, 2024
Approval ID
ae9730a7bc1b9356
Type
Standard
Back to CIMA-AEMPS Approvals